US Stock MarketDetailed Quotes

TARO Taro Pharmaceutical Industries

Watchlist
  • 42.970
  • 0.0000.00%
Trading Jul 25 09:30 ET
1.27BMarket Cap30.05P/E (TTM)

Taro Pharmaceutical Industries Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
292.30%124.56M
-32.33%38.34M
142.23%30.93M
133.37%47.52M
113.40%7.78M
120.01%31.75M
37.31%56.65M
106.65%12.77M
139.14%20.36M
-231.90%-58.03M
Net income from continuing operations
111.70%53.87M
118.14%15.08M
178.08%20.21M
403.87%8.55M
-28.74%10.03M
-56.33%25.45M
-74.78%6.91M
-72.38%7.27M
-112.06%-2.81M
175.02%14.08M
Operating gains losses
-103.58%-86K
-45.75%453K
-416.67%-741K
89.03%1.16M
-231.81%-953K
714.58%2.4M
327.52%835K
135.19%234K
-56.36%611K
195.26%723K
Depreciation and amortization
-3.22%31.09M
-23.92%8.22M
0.66%7.37M
8.41%7.61M
13.10%7.89M
23.97%32.13M
62.10%10.81M
13.53%7.33M
8.79%7.02M
9.96%6.98M
Deferred tax
13.96%19.15M
14.51%13.96M
11.96%2.65M
194.12%160K
-1.49%2.38M
-27.58%16.8M
48.71%12.19M
223.02%2.37M
-102.99%-170K
-78.52%2.42M
Other non cash items
----
----
----
----
----
---15.29M
----
----
----
----
Change In working capital
174.13%28.1M
-94.65%2.16M
197.95%4.64M
136.92%30.15M
89.74%-8.85M
86.41%-37.91M
745.92%40.27M
97.89%-4.73M
113.84%12.73M
-296.97%-86.17M
-Change in receivables
1.23%40.21M
-70.58%11.06M
-70.50%-2.64M
139.16%56.1M
-22.85%-24.31M
440.09%39.72M
426.30%37.6M
89.36%-1.55M
15.61%23.46M
-235.79%-19.79M
-Change in inventory
228.40%21.73M
318.35%9.96M
6.50%-6.59M
-389.68%-3.62M
434.71%21.98M
-717.88%-16.92M
-5,465.88%-4.56M
-1,561.62%-7.05M
1,938.24%1.25M
-155.69%-6.57M
-Change in payables and accrued expense
44.26%-33.84M
-360.92%-18.87M
259.20%13.87M
-86.36%-22.32M
89.11%-6.51M
77.12%-60.71M
38.95%7.23M
101.83%3.86M
89.32%-11.98M
-214.57%-59.82M
Cash from discontinued investing activities
Operating cash flow
292.30%124.56M
-32.33%38.34M
142.23%30.93M
133.37%47.52M
113.40%7.78M
120.01%31.75M
37.31%56.65M
106.65%12.77M
139.14%20.36M
-231.90%-58.03M
Investing cash flow
Cash flow from continuing investing activities
167.18%84.34M
-957.00%-57.2M
184.91%81.67M
239.23%98.57M
-211.36%-38.7M
26.40%-125.56M
106.15%6.67M
-586.00%-96.19M
-124.56%-70.79M
311.57%34.76M
Net PPE purchase and sale
-176.02%-53.97M
31.37%-5.74M
-344.65%-34.43M
-411.83%-7.01M
-227.53%-6.79M
82.40%-19.55M
91.79%-8.37M
-135.35%-7.74M
30.72%-1.37M
46.20%-2.07M
Net intangibles purchase and sale
15.99%-247K
13.95%-148K
9.26%-49K
102.94%1K
-50.00%-51K
-20.99%-294K
-39.84%-172K
-315.38%-54K
2.86%-34K
52.78%-34K
Net business purchase and sale
----
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
231.08%138.56M
-437.25%-51.31M
231.40%116.15M
252.15%105.58M
-186.43%-31.86M
-58.56%-105.71M
209.16%15.21M
-724.65%-88.39M
-135.10%-69.39M
394.90%36.86M
Cash from discontinued investing activities
Investing cash flow
167.18%84.34M
-957.00%-57.2M
184.91%81.67M
239.23%98.57M
-211.36%-38.7M
26.40%-125.56M
106.15%6.67M
-586.00%-96.19M
-124.56%-70.79M
311.57%34.76M
Financing cash flow
Cash flow from continuing financing activities
0
Net common stock issuance
----
----
----
----
----
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
----
----
--0
--0
--0
--0
--0
--0
--0
--0
Net cash flow
Beginning cash position
-38.48%154.5M
315.78%382.41M
53.55%269.01M
-45.01%124.17M
-38.48%154.5M
-58.50%251.13M
-71.09%91.97M
-66.55%175.19M
-63.28%225.8M
-58.50%251.13M
Current changes in cash
322.69%208.9M
-129.78%-18.86M
234.97%112.6M
389.66%146.09M
-32.89%-30.93M
73.52%-93.81M
194.03%63.32M
59.49%-83.42M
44.06%-50.43M
-351.68%-23.27M
Effect of exchange rate changes
82.95%-483K
20.20%-640K
288.35%800K
-600.56%-1.24M
128.98%597K
-1,766.47%-2.83M
-311.61%-802K
-47.18%206K
83.35%-177K
-543.97%-2.06M
End cash Position
134.90%362.91M
134.90%362.91M
315.78%382.41M
53.55%269.01M
-45.01%124.17M
-38.48%154.5M
-38.48%154.5M
-71.09%91.97M
-66.55%175.19M
-63.28%225.8M
Free cash flow
490.92%70.34M
-32.56%32.45M
-171.49%-3.55M
113.68%40.51M
101.55%933K
104.41%11.9M
179.11%48.11M
102.55%4.97M
135.09%18.96M
-250.09%-60.14M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 292.30%124.56M-32.33%38.34M142.23%30.93M133.37%47.52M113.40%7.78M120.01%31.75M37.31%56.65M106.65%12.77M139.14%20.36M-231.90%-58.03M
Net income from continuing operations 111.70%53.87M118.14%15.08M178.08%20.21M403.87%8.55M-28.74%10.03M-56.33%25.45M-74.78%6.91M-72.38%7.27M-112.06%-2.81M175.02%14.08M
Operating gains losses -103.58%-86K-45.75%453K-416.67%-741K89.03%1.16M-231.81%-953K714.58%2.4M327.52%835K135.19%234K-56.36%611K195.26%723K
Depreciation and amortization -3.22%31.09M-23.92%8.22M0.66%7.37M8.41%7.61M13.10%7.89M23.97%32.13M62.10%10.81M13.53%7.33M8.79%7.02M9.96%6.98M
Deferred tax 13.96%19.15M14.51%13.96M11.96%2.65M194.12%160K-1.49%2.38M-27.58%16.8M48.71%12.19M223.02%2.37M-102.99%-170K-78.52%2.42M
Other non cash items -----------------------15.29M----------------
Change In working capital 174.13%28.1M-94.65%2.16M197.95%4.64M136.92%30.15M89.74%-8.85M86.41%-37.91M745.92%40.27M97.89%-4.73M113.84%12.73M-296.97%-86.17M
-Change in receivables 1.23%40.21M-70.58%11.06M-70.50%-2.64M139.16%56.1M-22.85%-24.31M440.09%39.72M426.30%37.6M89.36%-1.55M15.61%23.46M-235.79%-19.79M
-Change in inventory 228.40%21.73M318.35%9.96M6.50%-6.59M-389.68%-3.62M434.71%21.98M-717.88%-16.92M-5,465.88%-4.56M-1,561.62%-7.05M1,938.24%1.25M-155.69%-6.57M
-Change in payables and accrued expense 44.26%-33.84M-360.92%-18.87M259.20%13.87M-86.36%-22.32M89.11%-6.51M77.12%-60.71M38.95%7.23M101.83%3.86M89.32%-11.98M-214.57%-59.82M
Cash from discontinued investing activities
Operating cash flow 292.30%124.56M-32.33%38.34M142.23%30.93M133.37%47.52M113.40%7.78M120.01%31.75M37.31%56.65M106.65%12.77M139.14%20.36M-231.90%-58.03M
Investing cash flow
Cash flow from continuing investing activities 167.18%84.34M-957.00%-57.2M184.91%81.67M239.23%98.57M-211.36%-38.7M26.40%-125.56M106.15%6.67M-586.00%-96.19M-124.56%-70.79M311.57%34.76M
Net PPE purchase and sale -176.02%-53.97M31.37%-5.74M-344.65%-34.43M-411.83%-7.01M-227.53%-6.79M82.40%-19.55M91.79%-8.37M-135.35%-7.74M30.72%-1.37M46.20%-2.07M
Net intangibles purchase and sale 15.99%-247K13.95%-148K9.26%-49K102.94%1K-50.00%-51K-20.99%-294K-39.84%-172K-315.38%-54K2.86%-34K52.78%-34K
Net business purchase and sale ----------------------0----------------
Net investment purchase and sale 231.08%138.56M-437.25%-51.31M231.40%116.15M252.15%105.58M-186.43%-31.86M-58.56%-105.71M209.16%15.21M-724.65%-88.39M-135.10%-69.39M394.90%36.86M
Cash from discontinued investing activities
Investing cash flow 167.18%84.34M-957.00%-57.2M184.91%81.67M239.23%98.57M-211.36%-38.7M26.40%-125.56M106.15%6.67M-586.00%-96.19M-124.56%-70.79M311.57%34.76M
Financing cash flow
Cash flow from continuing financing activities 0
Net common stock issuance ----------------------0----------------
Cash from discontinued financing activities
Financing cash flow ----------0--0--0--0--0--0--0--0
Net cash flow
Beginning cash position -38.48%154.5M315.78%382.41M53.55%269.01M-45.01%124.17M-38.48%154.5M-58.50%251.13M-71.09%91.97M-66.55%175.19M-63.28%225.8M-58.50%251.13M
Current changes in cash 322.69%208.9M-129.78%-18.86M234.97%112.6M389.66%146.09M-32.89%-30.93M73.52%-93.81M194.03%63.32M59.49%-83.42M44.06%-50.43M-351.68%-23.27M
Effect of exchange rate changes 82.95%-483K20.20%-640K288.35%800K-600.56%-1.24M128.98%597K-1,766.47%-2.83M-311.61%-802K-47.18%206K83.35%-177K-543.97%-2.06M
End cash Position 134.90%362.91M134.90%362.91M315.78%382.41M53.55%269.01M-45.01%124.17M-38.48%154.5M-38.48%154.5M-71.09%91.97M-66.55%175.19M-63.28%225.8M
Free cash flow 490.92%70.34M-32.56%32.45M-171.49%-3.55M113.68%40.51M101.55%933K104.41%11.9M179.11%48.11M102.55%4.97M135.09%18.96M-250.09%-60.14M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Advanced Micro Devices
AMD
-0.25%
ASML Holding
ASML
-0.50%
Taiwan Semiconductor
TSM
-0.84%
Disney
DIS
-0.97%
Cisco
CSCO
-1.01%

Unlock the Full List